Flu Vaccine Market is expected to reach US$ 10.74 billion by 2033 | Top Companies - AstraZeneca, Sanofi, Pfizer Inc.

Market Size and Growth:

The Global Flu Vaccine Market Size reached US$ 5.70 billion in 2024 and is expected to reach US$ 10.74 billion by 2033, growing at a CAGR of 7.3% during the forecast period 2025-2033. The Market is growing due to increasing awareness of influenza prevention, rising government vaccination programs, and expanding healthcare infrastructure worldwide. According to DataM Intelligence Report.

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/flu-vaccine-market?sz

The Flu Vaccine Market encompasses the research, development, production, and distribution of vaccines designed to prevent influenza infections. It includes seasonal and pandemic flu vaccines, targeting various age groups and risk populations. Market growth is driven by rising influenza incidence, government immunization programs, and increasing public awareness about vaccination benefits for health protection and disease prevention.

Industry Recent Developments: United States

✅ In September 2025, FluMist received FDA approval for self- or caregiver administration, enhancing accessibility for the 2025-2026 season.

✅ In November 2025, manufacturers projected a supply of up to 154 million doses for the 2025-2026 season, with most being thimerosal-free.

✅ In November 2025, concerns arose over declining vaccination rates, with about 26.5 million doses administered by late October, down over 2 million from the prior year.

Industry Recent Developments: Japan

✅ In October 2025, health authorities declared a nationwide flu epidemic after cases surged to over 6,000 by early October, leading to school closures.

✅ In November 2025, a health ministry panel endorsed adding Sanofi's high-dose flu vaccine Efluelda to the national immunization program for adults aged 75 and older.

✅ In November 2025, influenza activity peaked early due to the H3N2 subclade K variant, accounting for 80% of cases and over 57,000 reported infections by mid-month.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/flu-vaccine-market?sz

FDA / Regulatory Approvals in 2025:

✅ The FDA - via its annual review process - selected the influenza virus strains for the 2025-2026 U.S. flu vaccine season. Vaccine makers updated their formulations accordingly.

✅ In July 2025, the FDA granted licensing / lot‐release approval for two major seasonal flu vaccines, FluLaval and FluArix (single‐dose, pre‐filled syringes), making them available for people aged 6 months and older for the 2025‐26 flu season.

✅ As part of standard seasonal readiness, major manufacturers also began shipping doses to U.S. healthcare providers and pharmacies ahead of the flu season.

✅ Meanwhile, in the broader vaccine‐development space, companies continue pushing next‐generation flu shots: e.g., Novavax reported in mid‐2025 that its COVID‐19 + influenza combination and stand-alone seasonal influenza vaccine candidates produced robust immune responses in an initial cohort of a Phase 3 trial - though these candidates are not yet approved.

✅ On the other hand, Moderna, Inc. voluntarily withdrew its 2025 application for a combined flu + COVID‐19 vaccine (mRNA‐1083) in consultation with the FDA, choosing to wait for efficacy data from its standalone flu shot candidate (mRNA‐1010) before resubmitting.

Major Key Players:

AstraZeneca
Sanofi
CSL
Serum Institute of India Pvt. Ltd
Viatris Inc.
Hualan Biological Engineering Inc
Sinovac Biotech Ltd.
GSK Plc
Pfizer Inc.
CureVac N.V.

Segments Covered in the Flu Vaccine Market:

By Type: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines.

By Application: Children Less than 3 Years, Adults and Children Greater than 3 years.

Regional Analysis for Flu Vaccine Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=flu-vaccine-market

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Flu Vaccine market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Flu Vaccine Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Flu Vaccine market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Flu Vaccine Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Flu Vaccine market?

➠ Who are the global key manufacturers of the Flu Vaccine Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Flu Vaccine market opportunities and threats faced by the vendors in the global Flu Vaccine Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Flu Vaccine market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.